Apr 17, 2025
SonoVascular, Inc., a clinical stage medical device company focused on bringing to market its SonoThrombectomy™ System, a safer and more effective treatment of venous thromboembolism (VTE), was awarded the Angel Capital Association's 2025 Luis Villalobos Award in the Life Science category at the Summit of Angel Investing conference in Denver, CO.
The Angel Capital Association (ACA), the world’s largest professional development organization for angel investors, representing over 15K angel investors, 250 angel groups, and +30K entrepreneurial companies, awarded SonoVascular, a Wolfpack Investor Network (WIN) portfolio company, the 2025 Luis Villalobos Award in the Life Sciences category.
